TAM
SAGE

Tiverton Asset Management’s Sage Therapeutics SAGE Stock Holding History

Tiverton Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.06M Hold
7,550
– – 0.04% 289
2019
Q2 		$1.38M Buy
7,550
+27
+0.4% +$4.61K 0.05% 233
2019
Q1 		$1.2M Buy
7,523
+1,323
+21% +$192K 0.05% 220
2018
Q4 		$594K Sell
6,200
-306
-5% -$35K 0.04% 218
2018
Q3 		$919K Buy
6,506
+5,044
+345% +$779K 0.05% 205
2018
Q2 		$229K Buy
+1,462
New +$230K 0.01% 303

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return